mTORC1综合征 (TorS):这是PASC,ME/CFS和PAIS的统一范式
1Hebrew University Medical School, 91120, Jerusalem, Israel. jacobb@ekmd.huji.ac.il.
Journal of translational medicine
|March 10, 2025
概括
像PASC和ME/CFS这样的后急性感染综合征共享症状,但缺乏确定的原因. mTORC1综合征 (TorS) 可能解释了它们的共同病理生理学,提供了对驱动因素,脆弱性和潜在治疗方法的见解.
科学领域:
- 医学研究 医学研究
- 病理生理学 病理生理学
- 综合症分析 综合症分析
背景情况:
- 后急性SARS-Cov2 (PASC),肌痛性脑脊髓炎/慢性疲劳综合征 (ME/CFS) 和后急性感染综合征 (PAIS) 是具有重叠症状的慢性疾病,如疲劳和认知功能障碍.
- 这些综合征的潜在病理生理学和风险因素仍然不明,导致治疗需求未得到满足.
- 目前的理解缺乏对这些不同但相似的后感染性疾病中共享的驱动因素和机制的统一解释.
研究的目的:
- 为PASC,ME/CFS和PAIS提出一个统一的病理生理学框架.
- 研究哺乳动物目标拉巴素C1 (mTORC1) 过激活的作用,作为这些综合征的潜在驱动因素.
- 探索该框架如何为了解脆弱性提供信息,并指导治疗策略.
主要方法:
- 关于PASC,ME/CFS,PAIS和mTORC1信号的现有文献的概念审查和综合.
- 分析共享的临床表现和拟议的病理生理联系.
- 将"mTORC1综合征" (TorS) 假设与急性后感染综合征的特征进行整合.
主要成果:
- 该研究认为,mTORC1的持续过度激活,称为"mTORC1综合征" (TorS),可能是PASC,ME/CFS和PAIS的共同症状和病理生理学的基础.
- TorS为这些综合征中观察到的各种表现提供了潜在的解释,将它们与更广泛的代谢和细胞失调联系起来.
- 这种假设为识别脆弱因素和开发有针对性的治疗干预提供了潜在的框架.
结论:
- 拟议的"mTORC1综合征" (TorS) 提供了对PASC,ME/CFS和PAIS的一致的病理生理洞察.
- 了解TorS可能会阐明驱动因素,脆弱性因素,并最终导致这些衰弱的慢性疾病的新治疗选择.
- 需要进一步的研究来验证mTORC1过激活在这些综合征中的作用及其治疗影响.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:07MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K